Related Experiment Video

Updated: May 19, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Metronidazole treatment for acute phase amoebic liver abscess in patients co-infected with HIV

K Ohnishi1, F Uchiyama-Nakamura

  • 1Department of Infectious Diseases, Tokyo Metropolitan Bokutoh General Hospital, Sumida City, Tokyo 130-8575, Japan. infection@bokutoh-hp.metro.tokyo.jp

International Journal of STD & AIDS
|August 30, 2012
PubMed

Insights

Metronidazole effectively treats invasive amoebiasis in HIV-positive patients. Standard doses showed no adverse effects, and treatment success was independent of CD4 count or viral load.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • HIV Medicine

Background:

  • Invasive amoebiasis requires prompt treatment, with metronidazole as the primary agent.
  • The optimal use of metronidazole in human immunodeficiency virus (HIV)-infected individuals with invasive amoebiasis remains unclear.
  • HIV infection can alter drug metabolism and treatment responses, necessitating specific considerations.

Purpose of the Study:

  • To evaluate the efficacy and safety of standard metronidazole dosing for invasive amoebiasis in HIV-positive patients.
  • To determine if HIV disease parameters, such as CD4 cell count or viral load, impact metronidazole treatment outcomes.

Main Methods:

  • A cohort of seven HIV-positive patients with acute amoebic liver abscess was studied.
  • Patients received oral metronidazole at 1500 mg daily for 10 days.
  • Clinical outcomes, need for abscess drainage, side effects, CD4 counts, and HIV viral loads were monitored.

Main Results:

  • Metronidazole treatment was successful in all seven patients.
  • No patients required surgical drainage of the liver abscess.
  • Metronidazole was well-tolerated, with no serious adverse events reported.
  • Treatment efficacy was not influenced by baseline CD4 cell counts or HIV viral load.

Conclusions:

  • Standard oral metronidazole therapy is effective and safe for treating invasive amoebiasis in HIV-positive individuals.
  • Dosage or duration adjustments for metronidazole are not necessary in this patient population.
  • HIV disease severity, as indicated by CD4 count or viral load, does not appear to affect treatment outcomes.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...